 Sarepta Therapeutics Inc. SRPT, -9.77 said Wednesday it has priced 980 million of convertible senior unsecured notes that mature in September of 2027. The company will reduce the potential dilution of issuing new shares by entering capped call transactions with one or more dealers. 